Emerging Opportunities and Challenges of Nanoparticles in Nanomedicine
Author:
Bhuiyan Mohammad Ruhul AminORCID, Mamur Hayati1ORCID, Üstüner Mehmet AliORCID, Korucu Haluk2ORCID
Affiliation:
1. MANİSA CELAL BAYAR ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ, ELEKTRİK-ELEKTRONİK MÜHENDİSLİĞİ 2. CANKIRI KARATEKIN UNIVERSITY
Abstract
Nanomedicine encompasses a wide range of utilizations, including medical biological devices, nanoparticles (NPs), nanoelectronic biosensors, and possible future applications of molecular nanotechnologies, such as biological machines. Understanding toxicity and environmental impact problems is a current challenge in nanomedicine. The advancement of NPs in nanomedicine foresees emerging opportunities that may change healthcare by enhancing pharmaceutical effectiveness. This review may reveal novel and improved biomedical significance by delving deeper into advanced growth methodologies and NP applications in nanomedicine. NPs' outstanding physical and chemical characteristics have advanced medical, diagnostic, and screening techniques. The present review offers a current overview of organic and inorganic nanoparticles, highlighting recent advancements, obstacles, and potential applications for nanomedicine. Also, the focus of this review is on a fundamental concept that underlies the creation of novel and successful therapies using NPs in the field of nanomedicine for the human body's lungs, heart, brain, and kidneys. This extensive and insightful information source would be beneficial to the advancement of nanomedicine.
Publisher
Gazi University Journal of Science
Reference102 articles.
1. [1] Xiao, S., and Chen, L., “The emerging landscape of nanotheranostic-based diagnosis and therapy for osteoarthritis”, Journal of Controlled Release, 328: 817–833, (2020). 2. [2] Wang, L., Pan, H., Gu, D. Sun, H., Chen, K., Tan, G., and Pan, W., “A novel carbon dots/thermo-sensitive in situ gel for a composite ocular drug delivery system: characterization, ex-vivo imaging and in vivo evaluation”, International Journal of Molecular Sciences, 22(18): 9934, (2021). 3. [3] Meng, Q., Zhong, S., He, S., Gao, Y., and Cui, X., “Synthesis and characterization of curcumin-loaded pH/reduction dual-responsive folic acid modified carboxymethyl cellulose-based microcapsules for targeted drug delivery”, Journal of Industrial and Engineering Chemistry, 105: 251–258, (2022). 4. [4] LaVan, D. A., McGuire, T., and Langer, R., “Small-scale systems for in vivo drug delivery”, Nature Biotechnology, 21: 1184-1191, (2003). 5. [5] Shevchenko, K. G., Garkushina, I. S., Canfarotta, F., Piletsky, S. A., and Barlev, N. A., “Nano-molecularly imprinted polymers (nanoMIPs) as a novel approach to targeted drug delivery in nanomedicine”, RSC Advances, 12: 3957–3968, (2022).
|
|